“The completion of our deal signals a new era in the dialysis industry, uniting two patient-focused, physician driven and employee-oriented companies with great autonomy to build their brands,” said Mark Caputo, founder of Liberty Dialysis and CEO of the combined organization. “This transaction allows us to take advantage of the combined financial strength, purchasing power, and systems investment of two leaders in the industry.”
The transaction was completed on Dec. 17, and the combined organization has 5,300 employees serving more than 19,000 patients in 260 locations in 32 states.
The two companies will keep their autonomy, and will continue to operate under their current brand names—Renal Advantage and Liberty Dialysis—in the markets they serve nationwide. The merger creates a shared services organization supporting the two sister companies, which can achieve greater purchasing power and economies of scale.
“As we begin a new year with change on the health care horizon, we are well positioned for robust growth in the future through this deal,” said Michael D. Klein, who has served as chief executive officer of RAI. “By focusing on the patient, partnering with talented nephrologists, and recruiting the best caregivers, we will optimize patient outcomes through active participation of both patients and caregivers.”
